Vitamin D deficiency in young children with severe acute lower respiratory infection

Pediatric Pulmonology

Volumn 44, Issue 10, 2009, Pages 981-988

  McNally, J Dayre ^a   Leis, Karen ^a   Matheson, Loren A ^a   Karuananyake, Chandima ^a   Sankaran, Koravangattu ^a   Rosenberg, Alan M ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Bronchiolitis; Pediatrics; Pneumonia; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

AGE DISTRIBUTION; ARTICLE; BRONCHIOLITIS; CANADA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL MANAGEMENT; HUMAN; INFANT; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; PEDIATRIC WARD; PNEUMONIA; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ACUTE DISEASE; AGE DISTRIBUTION; BRONCHIOLITIS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; ODDS RATIO; PNEUMONIA; PROBABILITY; REFERENCE VALUES; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; SASKATCHEWAN; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70349485578     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21089     Document Type: Article

References (45)

1. Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet 1999;354:590-592.
2. Canadian Institute of Child Health. The Health of Canada's Children: ACICH Profile, 3rd edition. Ontario: Canadian Institute of Child Health. 2000.
3. Whitney CG, Harper SA. Lower respiratory tract infections: prevention using vaccines. Infect Dis Clin North Am 2004; 18:899-917. (Pubitemid 39536015)
4. Nielsen HE, Siersma V, Andersen S, Gahrn-Hansen B, Mordhorst CH, Norgaard-Pedersen B, Roder B, Sorensen TL, Temme R, Vestergaard BF. Respiratory syncytial virus infection - risk factors for hospital admission: a case-control study. Acta Paediatr 2003;92:1314-1321. (Pubitemid 37465177)
5. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003; 143:S112-S117. (Pubitemid 37456908)
6. Marrie TJ, Carriere KC, Jin Y, Johnson DH. Hospitalization for community-acquired pneumonia in Alberta First Nations Aboriginals compared with non-First Nations Albertans. Can Respir J 2004;11:336-342. (Pubitemid 39247991)
7. Chantry CJ, Howard CR, Auinger P. Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics 2006;117:425-432. (Pubitemid 46071605)
8. Hassan MK, Al-Sadoon I. Risk factors for severe pneumonia in children in Basrah. Trop Doct 2001;31:139-141. (Pubitemid 32575172)
9. Schanzer DL, Langley JM, Tam TW. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J 2006;25:795-800.
10. Saynajakangas P, Keistinen T, Tuuponen T. Seasonal fluctuations in hospitalisation for pneumonia in Finland. Int J Circumpolar Health 2001;60:34-40.
11. Grant WB. Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 2008;27:853.
12. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:1129-1140.
13. Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murguia De Sierra T, Simoes EA, Shaha S, Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect 2007;135:1077-1090. (Pubitemid 47487593)
14. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007;135:1095-1096. author reply 1097-1098.
15. Mansbach JM, Camargo CA, Jr. Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics 2008;122:177-179.
16. Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997;349:1801-1804. (Pubitemid 27257557)
17. Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. J Trop Pediatr 2004;50:364-368. (Pubitemid 40017231)
18. Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr 2004;58:563-567. (Pubitemid 38500124)
19. Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr 2007;63:473-477.
20. Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S. Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur J Clin Nutr 2007;63:297-299.
21. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EE. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ 1997;156:S703-S711. (Pubitemid 27117244)
22. Schluter P, Carter S, Kokaua J. Indices and perception of crowding in Pacific households domicile within Auckland, New Zealand: findings from the Pacific Islands Families Study. N Z Med J 2007;120:U2393.
23. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355:618-621. (Pubitemid 30099469)
24. Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL, Sufi S. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004;89-90:467-471. (Pubitemid 38844332)
25. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 2004;50:2195-2197. (Pubitemid 39425873)
26. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008;45:153-159. (Pubitemid 351724586)
27. Society CP. Vitamin D supplementation: recommendations for Canadian mother and infants. Paediatr Child Health 2007;12: 583-589.
28. Ginde AA, Mansbach JM, Camargo CA, Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-390.
29. Weiler HA, Leslie WD, Krahn J, Steiman PW, Metge CJ. Canadian Aboriginal women have a higher prevalence of vitamin D deficiency than non-Aboriginal women despite similar dietary vitamin D intakes. J Nutr 2007;137:461-465. (Pubitemid 46213465)
30. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007;137:447-452. (Pubitemid 46213463)
31. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179:2060-2063.
32. Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J Infect Dis 2008;197:676-680.
33. Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 2009;19:1-9.
34. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA 2002;287:3116-3126. (Pubitemid 34633987)
35. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003;88: 4623-4632. (Pubitemid 37357503)
36. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308-1310.
37. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25- dihydroxyvitamin D3 on human lymphocytes and monocyte/ macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986;98:311-322.
38. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D(3). J Cyst Fibros 2007;6:403-410. (Pubitemid 350028703)
39. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006;36:361-370. (Pubitemid 43257459)
40. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.
41. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173: 2909-2912.
42. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005;19:1067-1077. (Pubitemid 40946432)
43. Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, Meng X, Bose S. Role of human {beta}-defensin-2 during tumor necrosis factor-{alpha}/NF-{kappa}B- mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 2008;283:22417-22429.
44. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006;306:153-182.
45. Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, Meng X, Bose S. Role of human beta-defensin-2 during tumor necrosis factor-alpha/ NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 2008;283: 22417-22429.